There are 2949 resources available
Access, availability, and uptake of combination therapies in Europe
Presenter: Tim Wilsdon
Session: MSD - New approaches, old barriers: Will cancer patients get access to the combinations and early treatments they need?
Resources:
Webcast
Lung cancer diagnostic test needs: perspective from a thoracic oncologist
Presenter: Gabriela Fernandes
Session: Thermo Fisher Scientific - NGS Biomarker testing: Time matters . No longer need to wait for weeks, as this can now happen within days
Resources:
Webcast
Establishment of a large-scale Asian genomic screening platform to identify non-small cell lung cancer with rare driver oncogenes and clarify drug resistant mechanisms
Presenter: Koichi Goto
Session: Thermo Fisher Scientific - NGS Biomarker testing: Time matters . No longer need to wait for weeks, as this can now happen within days
Resources:
Webcast
NTRK, RET and other fusion biomarkers testing: Latest developments
Presenter: Philip Jermann
Session: Thermo Fisher Scientific - NGS Biomarker testing: Time matters . No longer need to wait for weeks, as this can now happen within days
Resources:
Webcast
Introduction
Presenter: Luca Quagliata
Session: Thermo Fisher Scientific - NGS Biomarker testing: Time matters . No longer need to wait for weeks, as this can now happen within days
Resources:
Webcast
Genomic profiling is driving the precision oncology
Presenter: Philip Jermann
Session: Thermo Fisher Scientific - NGS Biomarker testing: Time matters . No longer need to wait for weeks, as this can now happen within days
Resources:
Webcast
Welcome and introduction
Presenter: Neal Shore
Session: PeerVoice - Extending overall survival in nmCRPC while maintaining quality of life: Can we have it all?
Resources:
Webcast
Live Q&A - 24 September 2020 - 15:45-16:45
Presenter: Markus Möhler
Session: Bristol Myers Squibb - The future is now: Transforming management of GI cancer with immuno-oncology
Resources:
Webcast
Live Q&A - 24 September 2020 - 15:00-15:30
Presenter: George Demetri
Session: Pfizer Oncology - RWE and me: Multidisciplinary views on real-world evidence (RWE) in oncology
Resources:
Webcast
Live Q&A - 24 September 2020 - 15:30-16:00
Presenter: James Larkin
Session: Bristol Myers Squibb - Harnessing the Potential of the Immune System: Clinical Insights From Utilizing CTLA-4 Within a Dual I-O Approach in aRCC
Resources:
Webcast